Skip to main content


Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Figure 6 | BMC Genomics

Figure 6

From: Alternative splicing and differential gene expression in colon cancer detected by a whole genome exon array

Figure 6

PCR validation of candidate splicing events. PCR products are derived from forward/reverse primers in well-annotated flanking regions as indicated under the gene name. The interpretation of each change in mobility is given to the right ("Incl", include; "Ext", extended). The sample numbers match those in the sample data information (see Methods). Note that in several cases, an unlabeled doublet band results from a heteroduplex forming between the PCR products. Controls are "Universal Total RNA" (Clontech), an independent colon RNA sample (BioChain) and a No Template Control ("NTC"). "M" is a DNA ladder marker.

Back to article page